Cargando…
Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy
With the in-depth exploration on cancer therapeutic nanovaccines, increasing evidence shows that the poor delivery of nanovaccines to lymphoid organs has become the culprit limiting the rapid induction of anti-tumor immune response. Unlike the conventional prophylactic vaccines that mainly form a de...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620195/ https://www.ncbi.nlm.nih.gov/pubmed/34823541 http://dx.doi.org/10.1186/s12951-021-01146-2 |